Tags: finance , pharmaceuticals

M&A

As the year draws to a close, private-equity firm Actis orchestrates the sale of its portfolio company Paras Pharmaceuticals in India to Reckitt Benckiser for $726 million.

By Sameera Anand | 14 December 2010

M&A

Cardinal Health buys Yong Yu from Zuellig

US pharmaceutical distributor Cardinal Health agrees to pay $470 million for China’s largest pharmaceutical importer, Zuellig Pharma China, known locally as Yong Yu.

By Sameera Anand | 1 December 2010

M&A

Charles River buys WuXi PharmaTech in $1.6 billion deal

Pharmaceutical research company Charles River pays $1.6 billion in cash and stock to acquire Chinese outsourcing company WuXi PharmaTech two-and-a-half years after its listing ...

By Sameera Anand | 27 April 2010

M&A

Japan's Taisho buys select Asian assets from Bristol-Myers

Japanese firm Taisho Pharmaceutical pays $310 million for six Asia-Pacific brands and the Indonesian business of Bristol-Myers, as it seeks to build its presence in the OTC ...

By Sameera Anand | 17 September 2009

Equities	Debt
M&A	Moves People Moves Business Moves
News & Views View Point Macro & Markets Corporate	Banking Structured Products FX Private Banking
Editor's Desk Awards Co-published Editor's Desk Polls Book Review Private Capital	Conference Highlights
CorporateTreasury Cash Trade CorporateTreasury Moves Risk	Magazine Highlights

Tags: finance, pharmaceuticals

Tags: finance , pharmaceuticals